Details for 2013723910

Up to date per 01.04.2026

Actions

Title / Product Name

5-[[4-[[MORPHOLIN-2-YL]METHYLAMINO]-5-(TRIFLUORMETHYL)-2-PYRIDYL]AMINO]PYRAZIN-2-CARBONITRIL UND THERAPEUTISCHE VERWENDUNGEN DAVON

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2013723910

EP Publication Number

2855448

E-Number

866814

Language

PCT Number

GB13051233

Publication Date

08.04.2015 A

08.02.2017 B1

Registration Date

08.02.2017

AT Publication Date

15.02.2017

Application Date

14.05.2013

Registration Number

Priorities

15.05.2012

201261647200 P

IPC

C07D 401/12 20060101AFI20131205BHEP

Maximum Duration of Protection

14.05.2033

Owner

Cancer Research Technology LtdAngel Building, 407 St John Street London, Greater London EC1V 4ADGB

Representative

Häupl & Ellmeyer KG PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT

Inventor

COLLINS, IanThe Institute of Cancer Research 15 Cotswold Road Sutton Surrey SM2 5NGGB

MATTHEWS, Thomas PeterThe Institute of Cancer Research 15 Cotswold Road Sutton Surrey SM2 5NGGB

FARIA DA FONSECA MCHARDY, TatianaThe Institute of Cancer Research 15 Cotswold Road Sutton Surrey SM2 5NGGB

OSBORNE, JamesBiofocus Chesterford Research Park Chesterford Park Saffron Walden Essex CB10 1XLGB

LAINCHBURY, MichaelArgenta Discovery 2009 Limited 8-9 Spire Green Centre Flex Meadow Harlow Essex CM19 5TRGB

WALTON, Michael IanThe Institute of Cancer Research 15 Cotswold Road Sutton Surrey SM2 5NGGB

GARRETT, Michelle Dawn94 Grasmere Road Whitstable Canterbury Kent CT5 3EUGB

Information about Fees